Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair

Slides:



Advertisements
Similar presentations
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Patient Care WG Care Plan DAM July 19,
Advertisements

Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) June 26, 2013.
Concern Tracking What is it and why??. Concern Tracking time Patient Symptoms Concern Problem Observation Chest Pain, severe Visit I already have observation.
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Longitudinal Coordination of Care (LCC) Workgroup (WG)
Nursing Process- Evaluation. Evaluation Evaluation measures the client’s response to nursing actions and progress toward achieving health care goals.
1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.
HIT Standards Committee S&I and CDA – Update and Discussion November 16 th, 2011 Doug Fridsma, MD, PhD.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Patient Care WG Care Plan DAM July 31,
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) June 05, 2013.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) May 1, 2013.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Service Oriented Architecture (SOA) Care Coordination Services (CCS) May 29, 2013.
HL7 SDWG Topic October 29, 2015 David Tao.  HL7 Success! C-CDA 2.1 is cited, and Care Plan is in 2015 Edition Certification Final Rule  Common Clinical.
© 2012 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
Substance Abuse James May PH.D. Director SAS Richmond Behavioral Health Authority 2011.
Presented by Allergy/Intolerance/Adverse Reaction Concept Model HL7 Patient Care WG Discussion Pan Canadian Individual Care Standards Collaborative Working.
Longitudinal Coordination of Care (LCC) Workgroup (WG) HL7 Tiger Team Patient Care WG Care Plan DAM July 10,
© 2015 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Health Management Information Systems Unit 3 Electronic Health Records Component 6/Unit31 Health IT Workforce Curriculum Version 1.0/Fall 2010.
MULTICENTER RANDOMIZED CLINICAL TRIAL OF FSGS IN CHILDREN AND YOUNG ADULTS J Gassman, R Fine, A Friedman, D Gipson, T Greene, R Hogg, F Kaskel, M Moxey-Mims,
© 2013 Health Level Seven ® International. All Rights Reserved. HL7 and Health Level Seven are registered trademarks of Health Level Seven International.
HL7 C-CDA Survey and Implementation-A- Thon Final Report Summary Presentation to the HL7 Structured Documents Work Group on July 14, 2016.
C-CDA: Problem/Allergy Problem Status Observation Templates and Clinical Status Updates from Chicago WGM Stephen Chu, PCWG co-chair Russ Leftwich,
Networking and Health Information Exchange
QRDA I STU R5 Updates Since pre-ballot content Review
CRISP Update January 2017.
Nutrition in HL7 Standards
Nutrition in HL7 Standards
HL7 Care Plan Domain Analysis Model
Jack Millaway and Melody Robinson LPHI
CDA Document ‘Executive’ Summary Section
Chapter 15 Evaluating Dr. James Pelletier The Swain Department of Nursing.
“Next Generation of Connected Health”
Clinical Research: Part 3
HL7 WGM Madrid May 2017 Care Plan Standards Update
Clinical Status and related topics update
Clinical Status and related topics update
Setting the Stage Health information exchanges (HIEs) are participating in quality measurement through the Qualified Clinical Data Registry (QCDR) program.
Emergency Care Work Group
C-CDA: Problem/Allergy Problem Status Observation Templates and Clinical Status Post Madrid WGM update Stephen Chu, PCWG co-chair Emma Jones,
Patient Care Workgroup Care Plan Topic
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS
Clinical Status and related topics update
HL7 WGM Madrid May 2017 Care Plan Standards Update
Clinical Status and related topics update
Clinical Status and related topics update
HL7 Patient Care Work Group
Context Strategic Framework for CCKO
Clinical Status and related topics update
PCWG updates: Care Plan DAM CCS
Condition Resource - Overview
LHS – Care Team Value Sets
PCWG – May 2015 WGM Updates Morning Sessions.
To Admit…or not to Admit…that is the question!
PCWG updates: Part 1 Allergy/Intolerance Care Plan DAM CCS
Patient Care WG Allergy and Intolerances Project
Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair
Patient Care Work Group
Stephen Maisto, Professor of Psychology, College of Arts & Sciences, SU “Alcohol and other Substance Use: Treatment, Determinants, and Co-Morbidities”
Harm Reduction—not a new concept in integrated health care
Patient Care Elaine Ayres, Stephen Chu, Jean Duteau, Laura Heerman Langford, Russ Leftwich, Michael Tan Paris WGM 2015 Monday.
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
4. Allergy severity The severity of an allergy is not displayed by the CDA Display Tool, and this is considered relevant to the HP. PT MAJOR The severity.
Challenges Not Threats
Patient Care Elaine Ayres, Stephen Chu,
Patient Care WG Allergy and Intolerances Project
HL7 PCWG: Care Plan, CCS and Health Concern Updates
Sources of health outcomes data used in the SJLIFE study where severity grading criteria of long-term and late-onset health events were applied. Sources.
Presentation transcript:

PCWG – Chicago WGM C-CDA: Problem/Allergy Problem Status Observation Templates Stephen Chu, PCWG co-chair Russ Leftwich, PCWG co-chair Elaine Ayres, PCWG co-chair Laura Heermann Langford, PCWG co-chair Rob Hausam, vocab facilitator Lisa Nelson, PCWG Liaison from SDWG

Allergy Problem Observation in C-CDA 1.1 11/30/2018

Allergy Status Observation in C-CDA 1.1 Table 126: Allergy Status Observation 11/30/2018

Problem Observation in C-CDA 1.1 Health Status Observation: This template represents observations regarding the outcome of care from the interventions used to treat the patient. These observations represent status, at points in time, related to established care plan goals and/or interventions (Contains “Outcome Observation” template) Outcome Observation contains: Act Reference (NEW); Author Participation (NEW); Goal Observation (NEW); Intervention Act (NEW); Progress Toward Goal Observation (NEW) The “Problem Status” Observation uses the same HITSPProblemStatus values 11/30/2018

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated 11/30/2018

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated 11/30/2018

Determining Problem status in absence of Allergy Status Observation and Problem Status inadequate for expressing the rich semantics clinical status of the problem or concern statusCode: - metadata Not displayed as human readable data. How is that useful for expressing clinical status? Using “statusCode + effectiveTime to communicate “status”: inadequate 11/30/2018

In C-CDA 2.0 Allergy Status Observation and Problem Status templates are deprecated Determining “Problem Concern Status” in the absence of these templates: The statusCode of the Problem Concern Observation is the definitive indication of the status of the concern Issues Status of the concern = status of the Act (status of workflow) ≠ rich semantics of clinical status of the problem/concern The effectiveTime of the Problem Observation is the definitive indication of whether or not the underlying condition is resolved 11/30/2018

Determining Allergy Status The Allergy Status Observation template has been deprecated in Consolidated CDA Release 2 "Determining a Clinical Statement's Status", i.e. the status of an allergy is determined based on attributes of the Allergy Problem Act and Allergy - Intolerance Observation statusCode + effectiveTime 11/30/2018

Semantics of clinical status: much more complex The status of most clinical problems or conditions (allergy and intolerance included) need to be represented by one of the following values: Active Inactive (semantically different from resolved) Resolved Refuted 11/30/2018

Semantics of clinical status: much more complex Cancer, psychiatric/psychological problems (substances dependencies included) require additional status values: Remission states In remission Partial remission Full/complete remission Early full/partial remission Sustained full/partial remission Relapse states Relapse relapse after partial remission relapse after full remission 11/30/2018

Semantics of clinical status: much more complex The semantic complexity requires the reinstatement of: Problem status template Allergy status observation template 11/30/2018